Pratik Deb, MD, PhD

Assistant Professor and Attending Hematopahologist, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

[The Journal of Immunology @J_Immunol]

🎉#JI_TopRead ➡️ This study by @debpratik et al. reveals the effects of TLR10 expression in primary #human pDCs. #ReadTheJI #immunology @PFBocarsly

Read here what this means for innate responses: https://t.co/exvh5MABAn

[Pratik Deb, MD, PhD @debpratik]

#ASCP2024

[Huda Haq, MD @HudaHaq1]

Thrilled to be back @ASCP_Chicago Thank you for the warm welcome and wonderful learning environment.
@anueru432 Shu- great to see you, once again!! What a journey from residency applicants to residents in just a year. We made it 🙏

[Pratik Deb, MD, PhD @debpratik]

#ASCP2024

[TheBatoolMD @TheBatoolMD]

Hello, Chicago 🏙️🌇

Your pathology ninja has arrived.

♥️🥷♥️
#ASCP2024

[Pratik Deb, MD, PhD @debpratik]

#ASCP2024

[ASCP @ASCP_Chicago]

Residents who attended the TRIG Genomics 101 workshop to kick off the #ASCP2024 Annual Meeting in Chicago were introduced to introductory principles of genomic assays and interpretation of results in this small-group session.

[Pratik Deb, MD, PhD @debpratik]

#ASCP2024

[Shu Garcia (he/him) @anueru432]

#ASCP2024 Day 2 kicking off with #neuropath #molpath #moldx combo!

Excellent discussion on the applications of molecular in neuro!

#pathtwitter #pathX

[Shu Garcia (he/him) @anueru432]

#ASCP2024 Day 2 kicking off with #neuropath #molpath #moldx combo!

Excellent discussion on the applications of molecular in neuro!

#pathtwitter #pathX

[Pratik Deb, MD, PhD @debpratik]

#ASCP2024

[Kamran Mirza MD PhD - کامران مرزا @KMirza]

Kicked off #ASCP24 in #Chicago with an early morning coffee downtown with my daughter—now a college student in the city where she once ran around as a toddler!!

It’s a special kind of pride, seeing her thrive in the place that shaped both of us. Feeling that unique blend of nostalgia and joy, realizing how quickly time flies but also how rewarding it is!!

All set for the @ASCP_Chicago Board Meeting! #StrongerTogether

[Ankur Sangoi @slusagar]

#GUpath TURBT:
urothelial carcinoma with trophoblastic differentiation

(paired #IHCpath is HCG)

[Pratik Deb, MD, PhD @debpratik]

@kitagawa_yukiko Congratulations, Yukio! 👏 Where are you heading next?

[Pratik Deb, MD, PhD @debpratik]

@Tiger_heme @grzywacz_bartek @leon_metlay Wow, excellent case! This should definitely go into the literature. I've heard of PDGFRB-rearranged cases with B-ALL + myeloid counterparts and wonder how many cases of T/myeloid has been reported with PDGFRB-rearrangement!

[Pratik Deb, MD, PhD @debpratik]

@Tiger_heme Is there any myeloid differentiation in the lymph node? Or is it purely T-ALL?

[Pratik Deb, MD, PhD @debpratik]

Incredibly important discussion!

[ASCP @ASCP_Chicago]

Interested in unpacking the FDA's final rule on Laboratory Developed Tests? Our expert panelists help you navigate this new regulatory landscape and address any questions during this virtual town hall meeting at 12 PM CST on May 21. Register now: https://t.co/X0Nrh7KT3e

[ASCP @ASCP_Chicago]

Interested in unpacking the FDA's final rule on Laboratory Developed Tests? Our expert panelists help you navigate this new regulatory landscape and address any questions during this virtual town hall meeting at 12 PM CST on May 21. Register now: https://t.co/X0Nrh7KT3e

[Kathryn Golab, DCLS, MLS(ASCP)CM, SH-CM @KGolabMLS]

#LDTs and #FDAoversight have been a major talking point in the laboratory world for the last couple of months. Join the experts from @ASCP_Chicago to discuss what this means for your laboratory on May 21st!

[Pratik Deb, MD, PhD @debpratik]

@SibaElHussein @KMirza @AadilAhmedMD @MaracajaDLV @DanBabuMD @Kim_Ingersoll @cebulka26 @AnnaShestMD @katcollmd @kis_lorand @KarrsJeremiah Very interesting case! Recently saw a lenalidomide-induced B-ALL with partially mature phenotype (CD10 neg CD38 pos). TdT was still there (unlike this case).

[Siba El Hussein, MD @SibaElHussein]

Have you had a pediatric B-ALL with very mature features previously, that made you question whether you are dealing with a B-cell lymphoma instead? Below is a similar case:

Starting with CD38 expression: It is not as "dim" as you would expect it to be in B-ALL

#Hemepath #Leusm

[Siba El Hussein, MD @SibaElHussein]

Illustration of a rare case of intravascular large B-cell lymphoma with "anaplastic features", this variant is previously described, the cells are more pleomorphic than the typical large immunoblastic presentation

#dermpath , these cases go to you first typically & the neoplastic cells may be very sneaky, hiding in dermal vascular spaces

#hemepath #surgpath #PathTwitter #lymsm #MedTwitter

[Pratik Deb, MD, PhD @debpratik]

@NicolasDuployez Good enough for references 🙏

[Pratik Deb, MD, PhD @debpratik]

@katcollmd It was a smart move to include SMARCB1 deficiency in the name of the entity. Can't be board-tested that easily now😆